Ivyctory Solutions

Dr. Zaher Nahle's Boston engagements highlight pharmaceutical innovation, FDA modernization, scientific publishing, and public policy.

As Falling Walls 2026 convenes in Berlin, Dr. Zaher Nahle, Ivyctory Solutions CEO, reflects on his 2024 call to action and subsequent landmark FDA and HHS advances toward human-relevant biomedical research.

Dr. Zaher Nahle discusses FDA Modernization Acts 2.0 and 3.0 in ABC7/WJLA reporting and the nationally syndicated Full Measure investigation

Dr. Zaher Nahle delivers remarks on scientific and public policy priorities alongside Representatives Nick Langworthy (R-NY) and Mark Pocan (D-WI) at the introduction of the bipartisan COMPACT Act.

Frontiers publication examines scientific path dependency, evidentiary standards, and policy solutions for modernizing biomedical research